Recently the APH ConnectCenter Information and Referral Line received questions about the effects of Plaquenil (Hydroxychloroquine sulfate) on your eyes. This is of particular interest during the pandemic as Plaquenil has been discussed as a possible treatment for COVID-19. It was approved by the FDA for a short time as an emergency treatment for the virus at the beginning of the pandemic, until … Continued
Treatments for Dry Macular Degeneration: An Unmet Need Age-Related Macular Degeneration (AMD) is the leading cause of legal blindness in Americans over 65. There are two distinct types of the disease, both of which result in the deterioration of the macula, the central part of the retina that allows a person to see fine detail. … Continued
Treatments for Dry Macular Degeneration: An Unmet Need Age-Related Macular Degeneration (AMD) is the leading cause of legal blindness in Americans over 65. There are two distinct types of the disease, both of which result in the deterioration of the macula, the central part of the retina that allows a person to see fine detail. … Continued
One of the most significant challenges facing eye and vision researchers is developing an effective treatment for dry age-related macular degeneration (AMD). Although there are now a number of well-regarded FDA-approved drug treatments for wet AMD, the key to effective dry AMD treatment remains elusive, although several potential treatments have emerged in recent years. Current … Continued
New research from Johns Hopkins University School of Medicine reveals that the annual number of new cases of blindness and low vision among people aged 45 years and older is estimated to double during the next 30 years. Because data about the incidence of blindness and low vision in the United States was formally estimated … Continued
by Joy R. Efron, Ed.D. People have asked why I have written three series of articles about my experiences with macular hole and pseudo macular hole. The simple explanation is that I am attempting to reciprocate—to thank the many people who helped me—by helping others. My impressive visual recovery would not have been possible … Continued
One of the most significant challenges facing eye and vision researchers is developing an effective treatment for dry age-related macular degeneration (AMD). Although there are a number of well-regarded FDA-approved drug treatments for wet AMD, the key to effective dry AMD treatment continues to be elusive. Current treatments for dry AMD include a number of … Continued
Every year, during Eye Injury Prevention and Halloween Safety Month, I begin to get questions from friends and colleagues about the safety of decorative (also called “cosmetic,” “circle,” “costume,” or “non-prescription”) contact lenses. For the uninitiated, “circle lenses,” which first became popular in Asia about 10 years ago, are contact lenses that give the wearer … Continued
New research led by the AMD Center of Excellence at Harvard Medical School, the University of Coimbra, Portugal, and Brigham and Women’s Hospital has used an emerging field of study, called “metabolomics” (explained below), to test patients’ blood and identify blood profiles that are associated with age-related macular degeneration (AMD). According to study co-author Joan … Continued
On Monday, August 28, 2017, Scott Gottlieb, M.D., Commissioner of the United States Food and Drug Administration (FDA), announced a crackdown on stem cell clinics offering unproven and potentially dangerous treatments. Commissioner Gottlieb stated that he “will not allow deceitful actors to take advantage of vulnerable patients by purporting to have treatments or cures for … Continued